Viewing Study NCT02979951


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-02-23 @ 9:23 PM
Study NCT ID: NCT02979951
Status: RECRUITING
Last Update Posted: 2024-10-01
First Post: 2016-11-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Fosfomycin I.v. for Treatment of Severely Infected Patients
Sponsor: Infectopharm Arzneimittel GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bacterial Infections View
None Bone Diseases, Infectious View
None Osteomyelitis View
None Central Nervous System Bacterial Infections View
None Meningitis, Bacterial View
None Encephalitis View
None Brain Abscess View
None Urinary Tract Infections View
None Respiratory Tract Infections View
None Pneumonia, Bacterial View
None Skin Diseases, Bacterial View
None Soft Tissue Infections View
None Intraabdominal Infections View
None Sepsis View
None Bacteremia View
None Endocarditis, Bacterial View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Observational Study View
None Non-Interventional Study View
None Registries View
None Prospective View
None Monitored View
None Multicentric View
None International View
None Fosfomycin View
None Infectofos View
None Fomicyt View
None Bacterial Infections View
None Gram-Negative Bacterial Infections View
None Gram-Positive Bacterial Infections View
None Bone Diseases, Infectious View
None Osteomyelitis View
None Central Nervous System Bacterial Infections View
None Meningitis, Bacterial View
None Encephalitis View
None Brain Abscess View
None Urinary Tract Infections View
None Respiratory Tract Infections View
None Pneumonia, Bacterial View
None Skin Diseases, Bacterial View
None Soft Tissue Infections View
None Intraabdominal Infections View
None Sepsis View
None Bacteremia View
None Endocarditis, Bacterial View
None Treatment Outcome View
None Clinical Efficacy View
None Microbiological Efficacy View
None Safety View